Is Stryker Stock a Good Investment?

Stryker Investment Advice

SYK

To provide specific investment advice or recommendations on Stryker stock, we recommend investors consider the following general factors when evaluating Stryker. This will help you to make an informed decision on whether to include Stryker in one of your diversified portfolios:

Examine Stryker's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
Research Stryker's leadership team and their track record. Good management can help Stryker navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
Consider the overall health of the Health Care Equipment & Supplies space and any emerging trends that could impact Stryker's business and its evolving consumer preferences.
Compare Stryker's performance and market position to its competitors. Analyze how Stryker is positioned in terms of product offerings, innovation, and market share.
Check if Stryker pays a dividend and its dividend yield and payout ratio.
Review what financial analysts are saying about Stryker's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.

It's important to note that investing in Stryker stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Stryker is a good investment.

Sell

Buy

Hold

Macroaxis provides recommendation on Stryker to complement and cross-verify current analyst consensus on Stryker. Our trade recommendation engine determines the firm's potential to grow exclusively from the perspective of an investor's current risk tolerance and investing horizon. To make sure Stryker is not overpriced, please validate all Stryker fundamentals, including its current ratio, and the relationship between the ebitda and target price . Given that Stryker has a price to earning of 63.07 X, we advise you to double-check Stryker market performance and probability of bankruptcy to ensure the company can sustain itself in the current economic cycle given your current risk tolerance and investing horizon.

Market Performance	Very Weak	Details
Volatility	Very steady	Details
Hype Condition	Low key	Details
Current Valuation	Undervalued	Details
Odds Of Distress	Very Low	Details
Economic Sensitivity	Almost mirrors the market	Details
Investor Sentiment	Alarmed	Details
Analyst Consensus	Strong Buy	Details
Financial Strenth (F Score)	Healthy	Details
Financial Leverage	Not Rated	Details
Reporting Quality (M-Score)	Unlikely Manipulator	Details

Examine Stryker Stock

Researching Stryker's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 81.0% of the company shares are owned by institutional investors. The company has Price/Earnings To Growth (PEG) ratio of 2.2. Stryker recorded earning per share (EPS) of 7.56. The entity last dividend was issued on the 30th of June 2025. The firm had 2:1 split on the 17th of May 2004.

To determine if Stryker is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Stryker's research are outlined below:

	Stryker generated a negative expected return over the last 90 days
	Over 81.0% of the company shares are owned by institutional investors
	On 31st of July 2025 Stryker paid $ 0.84 per share dividend to its current shareholders
	Latest headline from thelincolnianonline.com: First Foundation Advisors Lowers Stake in Abbott Laboratories

Stryker Quarterly Good Will

19.09 Billion

Stryker uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Stryker. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Stryker's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.

	30th of January 2024 Upcoming Quarterly Report	View
	6th of May 2024 Next Financial Report	View
	31st of December 2023 Next Fiscal Quarter End	View
	30th of January 2024 Next Fiscal Year End	View
	30th of September 2023 Last Quarter Report	View
	31st of December 2022 Last Financial Announcement	View

Earnings surprises can significantly impact Stryker's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Stryker's investors have experienced.

Reported	Fiscal Date	Estimated EPS	Reported EPS	Surprise
1999-10-19	1999-09-30	0.09	0.1	0.01	11
1999-07-21	1999-06-30	0.09	0.1	0.01	11
1999-04-20	1999-03-31	0.08	0.09	0.01	12
1998-01-14	1997-12-31	0.09	0.1	0.01	11
1996-04-15	1996-03-31	0.06	0.07	0.01	16
2002-10-16	2002-09-30	0.19	0.21	0.02	10
2020-07-30	2020-06-30	0.57	0.64	0.07	12
2021-01-27	2020-12-31	2.55	2.81	0.26	10

Know Stryker's Top Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Stryker is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Stryker backward and forwards among themselves. Stryker's institutional investor refers to the entity that pools money to purchase Stryker's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.

		Shares
Bank Of New York Mellon Corp	2025-03-31	5.2 M
Fundsmith Llp	2025-03-31	5.1 M
Norges Bank	2024-12-31	4.8 M
Bank Of America Corp	2025-03-31	4 M
Fisher Asset Management, Llc	2025-03-31	3.7 M
Northern Trust Corp	2025-03-31	3.5 M
Franklin Resources Inc	2025-03-31	3.5 M
First Western Trust Bank	2025-03-31	3.3 M
Wells Fargo & Co	2025-03-31	2.2 M
Vanguard Group Inc	2025-03-31	33.1 M
Blackrock Inc	2025-03-31	27.2 M

Note, although Stryker's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Stryker's market capitalization trends

The company currently falls under 'Mega-Cap' category with a total capitalization of 144.38 B.

Market Cap

107.42 Billion

Stryker's profitablity analysis

	Last Reported	Projected for Next Year
Return On Tangible Assets	0.13	0.10
Return On Capital Employed	0.10	0.10
Return On Assets	0.07	0.11
Return On Equity	0.15	0.19

The company has Net Profit Margin of 0.12 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.19 %, which entails that for every 100 dollars of revenue, it generated $0.19 of operating income.

Determining Stryker's profitability involves analyzing its financial statements and using various financial metrics to determine if Stryker is a good buy. For example, gross profit margin measures Stryker's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Stryker's profitability and make more informed investment decisions.

Stryker's Earnings Breakdown by Geography

Evaluate Stryker's management efficiency

Stryker has Return on Asset of 0.0749 % which means that on every $100 spent on assets, it made $0.0749 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.1426 %, implying that it generated $0.1426 on every 100 dollars invested. Stryker's management efficiency ratios could be used to measure how well Stryker manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Stryker's Return On Assets are quite stable compared to the past year. Return On Equity is expected to rise to 0.19 this year, although the value of Return On Tangible Assets will most likely fall to 0.10. At this time, Stryker's Total Current Liabilities is quite stable compared to the past year. Liabilities And Stockholders Equity is expected to rise to about 45.1 B this year, although the value of Non Current Liabilities Other will most likely fall to about 1.8 B.

	Last Reported	Projected for Next Year
Book Value Per Share	54.16	56.87
Tangible Book Value Per Share	1.01	0.96
Enterprise Value Over EBITDA	25.74	13.20
Price Book Value Ratio	6.65	6.39
Enterprise Value Multiple	25.74	13.20
Price Fair Value	6.65	6.39
Enterprise Value	111.3 B	116.9 B

The strategic vision of Stryker management plays a critical role in its financial performance. By evaluating this vision, we provide insights into the stock's growth potential.

Forward Dividend Yield

0.0086

Forward Dividend Rate

3.36

Beta

0.922

Basic technical analysis of Stryker Stock

As of the 2nd of August, Stryker has the Semi Deviation of 1.07, coefficient of variation of 2921.01, and Risk Adjusted Performance of 0.0296. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Stryker, as well as the relationship between them.

Stryker's insider trading activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Stryker insiders, such as employees or executives, is commonly permitted as long as it does not rely on Stryker's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Stryker insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

		Spencer Stiles over a year ago Acquisition by Spencer Stiles of 8499 shares of Stryker subject to Rule 16b-3
		Yin Becker over a year ago Acquisition by Yin Becker of 3060 shares of Stryker at 339.77 subject to Rule 16b-3
		Ramesh Subrahmanian over a year ago Payment of 2378 shares by Ramesh Subrahmanian of Stryker subject to Rule 16b-3

Stryker's Outstanding Corporate Bonds

Stryker issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Stryker uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Stryker bonds can be classified according to their maturity, which is the date when Stryker has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

	STRYKER P 41 Corp Bond US863667AE17	View
	STRYKER P 3375 Corp Bond US863667AH48	View
	STRYKER P 4375 Corp Bond US863667AG64	View
	STRYKER P 4625 Corp Bond US863667AJ04	View
	STRYKER P 35 Corp Bond US863667AN16	View
	STRYKER P 365 Corp Bond US863667AQ47	View
	STRYKER PORATION Corp Bond US863667AY70	View
	US863667AZ46 Corp Bond US863667AZ46	View

View All Stryker Corporate Bonds

Understand Stryker's technical and predictive indicators

Using predictive indicators to make investment decisions involves analyzing Stryker's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.

	Risk Adjusted Performance	0.0296
	Market Risk Adjusted Performance	0.0373
	Mean Deviation	0.7987
	Semi Deviation	1.07
	Downside Deviation	1.12
	Coefficient Of Variation	2921.01
	Standard Deviation	1.07
	Variance	1.15
	Information Ratio	(0.07)
	Jensen Alpha	(0.07)
	Total Risk Alpha	(0.11)
	Sortino Ratio	(0.07)
	Treynor Ratio	0.0273
	Maximum Drawdown	4.39
	Value At Risk	(1.35)
	Potential Upside	1.88
	Downside Variance	1.25
	Semi Variance	1.14
	Expected Short fall	(0.83)
	Skewness	(0.57)
	Kurtosis	1.68

	Risk Adjusted Performance	0.0296
	Market Risk Adjusted Performance	0.0373
	Mean Deviation	0.7987
	Semi Deviation	1.07
	Downside Deviation	1.12
	Coefficient Of Variation	2921.01
	Standard Deviation	1.07
	Variance	1.15
	Information Ratio	(0.07)
	Jensen Alpha	(0.07)
	Total Risk Alpha	(0.11)
	Sortino Ratio	(0.07)
	Treynor Ratio	0.0273
	Maximum Drawdown	4.39
	Value At Risk	(1.35)
	Potential Upside	1.88
	Downside Variance	1.25
	Semi Variance	1.14
	Expected Short fall	(0.83)
	Skewness	(0.57)
	Kurtosis	1.68

Consider Stryker's intraday indicators

Stryker intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Stryker stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

	Accumulation Distribution	0.0281
	Daily Balance Of Power	(1.39)
	Rate Of Daily Change	0.96
	Day Median Price	377.71
	Day Typical Price	377.73
	Market Facilitation Index	10.77
	Price Action Indicator	(7.38)
	Period Momentum Indicator	(14.94)
	Relative Strength Index	58.69

Stryker Corporate Filings

10Q	1st of August 2025 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations	View Verify
8K	31st of July 2025 Report filed with the SEC to announce major events that shareholders should know about	View Verify
F3	4th of June 2025 The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock	View Verify
	30th of May 2025 Other Reports	View Verify

Stryker time-series forecasting models is one of many Stryker's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Stryker's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stryker Stock media impact

There is far too much social signal, news, headlines, and media speculation about Stryker that are available to investors today. This information is accessible both publicly - through Stryker's media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of Stryker-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.

A primary focus of Stryker news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Stryker relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Stryker's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Stryker alpha.

Stryker Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Stryker can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.

Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Stryker Historical Investor Sentiment

Investor biases related to Stryker's public news can be used to forecast risks associated with an investment in Stryker. The trend in average sentiment can be used to explain how an investor holding Stryker can time the market purely based on public headlines and social activities around Stryker. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.

Stryker's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Stryker and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Stryker news discussions. The higher the estimate score, the more favorable the investor's outlook on Stryker.

Stryker Maximum Pain Price Across September 19th 2025 Option Contracts

Stryker's options can also be used to analyze investors' bias and current market sentiment in the context of behavioral finance. For example, Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of Stryker close to the expiration of its current option contract to expire worthlessly. According to most research, about 35% of options are not executed, with roughly 50% traded out before expiration. So, Max pain occurs when market makers reach a net favorable position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthlessly. Please continue to view the detailed analysis of Stryker's options.

Stryker Corporate Directors

Andrew Silvernail	Independent Director	Profile
Sherilyn McCoy	Independent Director	Profile
Ronda Stryker	Independent Director	Profile
Allan Golston	Lead Independent Director	Profile

When determining whether Stryker is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Stryker Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Stryker Stock. Highlighted below are key reports to facilitate an investment decision about Stryker Stock: